overactive bladder
Conditions
Interventions
Insured drugs for overactive bladder are given at regular doses for 12 weeks.
Sponsors
Sapporo Medical University
Sanjyukai Hospital, Hokkaido Medical Center, NTT East Sapporo Hospital, Japan Community Health Care Organization (JCHO) Hokkaido Hospital,Oji Hospital, Muroran City General Hospital,Steel Memorial Muroran Hospital,Hakodate Goryokaku Hospital, Asahikawa Red Cross Hospital, Takikawa City Hospital,Sunagawa City Hospital, Obihiro Kyokai Hospital, Saka Urology Hospital, Kushiro Red Cross Hospital,Sapporo Central Hospital ,etc
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Overactive bladder patients (OABSS: total 3 points or more and question 3 2 points or more) (2) Consent to include in the study has been obtained (3) Being a new OAB treatment patient * Even if you have a history of treatment in the past, it is good if there is nothing you are currently taking
Exclusion criteria
Exclusion criteria: (1) Underage patients or patients whose sexual function cannot be evaluated (2) When the attending physician deems it inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fill in the questionnaire before and 12 weeks after the start of drug treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| At the same time, evaluate OABSS and residual urine volume | — |
Countries
Japan
Contacts
Public ContactWakako Yorozuya
Sapporo Medical University Department of Urology
Outcome results
None listed